or Try an Advanced Search...

    Technical Analysis for FEMY - Femasys Inc.

    Grade Last Price % Change Price Change
    F 1.02 4.40% 0.04
    FEMY closed up 10.27 percent on Wednesday, November 20, 2024, on 70 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Flat
    Historical FEMY trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 4.40%
    Gapped Up Strength 4.40%
    Oversold Stochastic Weakness 4.40%
    Wide Bands Range Expansion 15.12%
    Down 3 Days in a Row Weakness 15.12%
    Down 4 Days in a Row Weakness 15.12%
    Lower Bollinger Band Touch Weakness 15.12%
    Oversold Stochastic Weakness 15.12%
    Calm After Storm Range Contraction 9.48%
    Wide Bands Range Expansion 9.48%
    Older End-of-Day Signals for FEMY ...

       Recent Intraday Alerts

    Alert Time
    Up 5% 9 minutes ago
    10 DMA Resistance about 3 hours ago
    Rose Above 10 DMA about 3 hours ago
    Up 3% about 3 hours ago
    Up 2% about 3 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    FEMY Chart by TradingView
    Basic chart:

    Profile

    Femasys Inc. Description

    Femasys is a biomedical company focused on transforming women’s healthcare worldwide by developing novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. With an initial focus in the area of reproductive health, its two lead product candidates offer solutions to improve patient care and health economics: FemBloc, a first and only non-surgical product for permanent birth control and FemaSeed, a first and only directed sperm delivery product for infertility treatment. Femasys’ FemVue product for fallopian tube assessment by ultrasound is currently marketed in the United States as its main commercial priority. Femasys has also developed a novel technology platform for tissue sampling intended to be marketed alongside our other women-specific medical products in the physician’s office setting.

    Classification
    Sector: Healthcare
    Industry: Medical Instruments & Supplies
    Keywords: Ultrasound Birth Control Infertility Fertility Medicine Assisted Reproductive Technology

    Is FEMY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Femasys Third Quarter 2024 Earnings: Misses Expectations
    Nov 12 Femasys GAAP EPS of -$0.24, revenue of $554.91M
    Nov 12 Femasys Inc. (FEMY) Reports Q3 Loss, Tops Revenue Estimates
    Nov 12 Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update
    Nov 7 Femasys to Exhibit at the Annual AAGL 2024 Global Conference
    Nov 1 Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control
    Oct 30 Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed
    Oct 10 Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program
    Oct 8 Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
    Oct 2 Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments
    See more FEMY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.4
    52 Week Low 0.734
    Average Volume 169,688
    200-Day Moving Average 1.26
    50-Day Moving Average 1.15
    20-Day Moving Average 1.14
    10-Day Moving Average 1.02
    Average True Range 0.08
    RSI (14) 38.65
    ADX 30.74
    +DI 14.20
    -DI 29.46
    Chandelier Exit (Long, 3 ATRs) 1.15
    Chandelier Exit (Short, 3 ATRs) 1.11
    Upper Bollinger Bands 1.44
    Lower Bollinger Band 0.85
    Percent B (%b) 0.22
    BandWidth 51.86
    MACD Line -0.07
    MACD Signal Line -0.04
    MACD Histogram -0.0301
    Fundamentals Value
    Market Cap 21.15 Million
    Num Shares 21.6 Million
    EPS -0.98
    Price-to-Earnings (P/E) Ratio -1.00
    Price-to-Sales 23.96
    Price-to-Book 2.86
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.09
    Resistance 3 (R3) 1.08 1.03 1.07
    Resistance 2 (R2) 1.03 1.01 1.04 1.07
    Resistance 1 (R1) 1.01 0.99 1.02 1.02 1.06
    Pivot Point 0.96 0.96 0.96 0.96 0.96
    Support 1 (S1) 0.93 0.93 0.94 0.94 0.89
    Support 2 (S2) 0.88 0.91 0.89 0.89
    Support 3 (S3) 0.85 0.88 0.88
    Support 4 (S4) 0.86